Dr. Robert E. Sobol M.D.

• 
  www.sec.gov/Archives/edgar/data/1018710/0000950134-08-0 - [Cached Version]
  Published on: 4/29/2008    Last Visited: 8/10/2008  

  Robert E. Sobol, M.D.
  ...
  Robert E. Sobol, M.D. joined Introgen in September 2003 as our Senior Vice President, Medical and Scientific Affairs.He was President and Chief Executive Officer of Magnum Therapeutics Corporation, a biopharmaceutical company that Introgen acquired in October 2004, and previously served as President of Corautus Genetics Inc., a biopharmaceutical company.From 1998 to 2003, Dr. Sobol served as President and Chief Executive Officer of Genstar Therapeutics, a company that developed gene therapy products, which he founded in 1996.Dr. Sobol served as Vice President of IDEC Pharmaceuticals Corporation, a company he co-founded that pioneered monoclonal antibody based treatments for cancer and autoimmune disorders.Dr. Sobol received his M.D. from The Chicago Medical School.

• 
  www.oralcancerfoundation.org/news/story.asp?newsId=2140 - [Cached Version]
  Published on: 4/19/2008    Last Visited: 9/29/2008  

  'Advexin provides therapeutic benefit by restoring p53 tumor suppressor function which is blocked in the majority of head and neck cancers,' Robert E. Sobol, senior vice president, medical and scientific affairs, Introgen said in a statement.
  
  A comprehensive analysis of Introgen's phase three data and additional studies of Advexin will be presented at medical conferences later this year.

• 
  www.lead411.com/company.taf?_function=detail&Company_ui - [Cached Version]
  Published on: 1/2/2008    Last Visited: 4/1/2008  

  Robert Sobol [VCard] SVP Medical/Scientific Affairs

• 
  www.sec.gov/Archives/edgar/data/1018710/0001257433-06-0 - [Cached Version]
  Published on: 5/23/2006    Last Visited: 5/26/2006  

  0001218647 SOBOL ROBERT E 8395 SANTA FE RD SUITE B SAN DIEGO CA 92121 0 1 0 0 Senior Vice President

• 
  phx.corporate-ir.net/phoenix.zhtml?c=190273&p=irol-news - [Cached Version]
  Published on: 10/8/2007    Last Visited: 4/16/2008  

  Robert E. Sobol, M.D., Introgen's senior vice president of Medical and Scientific Affairs, is scheduled to present on Thursday, October 11, 2007, at 10:00 a.m. P.T.Dr. Sobol's presentation will be webcast live and will be available at www.introgen.com.

• 
  phx.corporate-ir.net/phoenix.zhtml?c=190273&p=irol-news - [Cached Version]
  Published on: 8/29/2007    Last Visited: 4/16/2008  

  Robert E. Sobol, M.D. Introgen's senior vice president of Medical and Scientific Affairs, is scheduled to present to leading institutional investment representatives on Thursday, September 6, 2007, at 8:00 a.m. ET, at the Four Seasons Boston.Dr. Sobol's presentation will be web cast live and will be available at http://www.veracast.com/webcasts/twp/healthcare07/95201474.cfm.

• 
  phx.corporate-ir.net/phoenix.zhtml?c=190273&p=irol-news - [Cached Version]
  Published on: 3/1/2005    Last Visited: 4/16/2008  

  AUSTIN, TX, Mar. 01, 2005 (MARKET WIRE via COMTEX) -- Introgen Therapeutics, Inc. (NASDAQ: INGN) announced today that Robert E. Sobol, M.D., Introgen's senior vice president of Medical and Scientific Affairs will present at the Wells Fargo Securities Healthcare Conference in New York on Wednesday, March 2, 2005 at 4:00 p.m. Eastern Time.Dr. Sobol will provide an overview of Introgen Therapeutics, discuss its clinical programs and review corporate objectives for 2005.
  
  A live web cast of Dr. Sobol's presentation may be accessed at http://www.wallstreetwebcasting.com/webcast/wfc/ingn.

• 
  www.sec.gov/Archives/edgar/data/1018710/0000950134-04-0 - [Cached Version]
  Published on: 5/14/2004    Last Visited: 7/28/2004  

  Robert E. Sobol, M.D.
  ...
  Robert E. Sobol, M.D. joined Introgen in September 2003 as our Senior Vice President, Medical and Scientific Affairs.He is currently the President and Chief Executive Officer of Magnum Therapeutics Corp., a biopharmaceutical company and was President of Corautus Genetics Inc., a biopharmaceutical company.From 1998 to 2003, Dr. Sobol served as President and Chief Executive Officer of Genstar Therapeutics, a company that developed gene therapy products, which he founded in 1996.Mr. Sobol received his M.D. from The Chicago Medical School.

• 
  www.sec.gov/Archives/edgar/data/1218647/0001426170-08-0 - [Cached Version]
  Published on: 5/20/2008    Last Visited: 5/21/2008  

  0001218647 SOBOL ROBERT E 8395 SANTA FE RD SUITE B SAN DIEGO CA 92121 0 1 0 0 Sr. Vice President

• 
  www.corporate-ir.net/ireye/ir_site.zhtml?ticker=ingn&sc - [Cached Version]
  Published on: 11/26/2008    Last Visited: 1/8/2009  

  In addition to David Nance, Max Talbott Ph.D., senior vice president, clinical affairs, Robert Sobol, M.D., senior vice president, medical and scientific affairs, and David Parker, Ph.D., JD, senior vice president, intellectual property have resigned their positions as officers of Introgen as a further step to preserve financial resources.

Page:  1 2 3 4 5